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COMMENT&RESPONSE
Association of a Genetic Risk ScoreWith
BodyMass Index
To the Editor Dr Walter and colleagues1 reported that a poly-
genic risk score for bodymass index (BMI) showed a differen-
tial association across different birth cohorts. For people born
between 1900 and 1958, the magnitude of association of the
risk score with BMI was reduced compared with people born
later. They suggested that changes in the environment may
modify theeffect of genetic variants associatedwithBMI.This
is an intriguing possibility. Obesity is a known risk factor for a
numberofadversehealthoutcomes that lead to increasedmor-
tality among individuals with high BMI.2,3
Ageneticvariantassociatedwithheavinessof smokingwas
differentially associated with smoking initiation (ie, ever vs
never) in different age groups.4 Among people younger than
50 years, the smoking-increasing allelewas positively associ-
atedwith smoking initiation,whereas amongpeople 50years
or older, it was negatively associatedwith smoking initiation.
This differential associationwas attributed to thehigher rates
Table 2. Prevalence Estimates, Differences, and Ratios of Structural Birth Defects AssociatedWith Receipt of Tdap During Pregnancy,
2007-2013
Prevalence (Rate per
10 000 Live Births)
(N = 324 463)a
Prevalence Difference
per 10 000 Live Births (95% CI) Prevalence Ratio (95% CI)
Tdap
Unexposed
Tdap
Exposed Unadjusted Adjustedb Unadjusted Adjustedb
Tdap During Any Pregnancy Week
No. of participants 282 809 41 654
Any structural birth defect 17 422 (616) 2816 (676) 60 (34 to 86) −13 (−41 to 15) 1.09 (1.05 to 1.14) 0.98 (0.94 to 1.03)
Selected birth defectsc 4521 (160) 717 (172) 12 (−1 to 26) 10 (−4 to 25) 1.08 (1.00 to 1.17) 1.06 (0.98 to 1.16)
Microcephaly 348 (12) 38 (9) −3 (−6 to 0) −1 (−4 to 2) 0.74 (0.53 to 1.04) 0.86 (0.60 to 1.24)
Tdap During First Trimester (<14 wk Gestation)
No. of participants 282 809 3321
Any structural birth defect 17 422 (616) 208 (626) 10 (−73 to 93) −51 (−132 to 30) 1.02 (0.89 to 1.17) 0.94 (0.82 to 1.07)
Selected birth defectsc 4521 (160) 59 (178) 18 (−27 to 63) 17 (−29 to 62) 1.11 (0.86 to 1.44) 1.10 (0.85 to 1.42)
Microcephaly 348 (12) 4 (12) 0 (−12 to 12) −1 (−12 to 9) 0.98 (0.37 to 2.62) 0.96 (0.36 to 2.58)
Tdap During Recommended Period (27-36 wk Gestation)c
No. of participants 120 097 20 568
Any structural birth defect 8367 (697) 1435 (698) 1 (−37 to 39) 14 (−25 to 53) 1.00 (0.95 to 1.06) 1.02 (0.96 to 1.08)
Selected birth defectsc 1920 (160) 356 (173) 13 (−6 to 32) 15 (−4 to 35) 1.08 (0.97 to 1.21) 1.09 (0.97 to 1.23)
Microcephaly 146 (12) 21 (10) −2 (−7 to 3) −1 (−5 to 4) 0.84 (0.53 to 1.33) 1.01 (0.63 to 1.61)
Abbreviation: Tdap, tetanus, diphtheria, and acellular pertussis.
a Pregnancy cohort was limited to 2010-2013 for California sites and
to 2012-2013 for other sites in Minnesota, Colorado, Oregon, Washington,
andWisconsin.
bAdjusted for propensity score includingmaternal age at delivery,
race/ethnicity, pregnancy delivery year, Kotelchuck Adequacy of Prenatal Care
Utilization Index, hospitalization at less than 20weeks’ gestation, maternal
smoking, preexisting hypertension, preexisting pulmonary, heart, or renal
conditions, site, andmean census tract poverty level.
c Diagnostic codes for selectedmajor structural birth defects:
spina bifida (741.0x and 741.9x); encephalocele, cranial meningocele,
or encephalomyelocele (742.0); microcephalus (742.1); holoprosencephaly
(742.2); anophthalmia or microphthalmia (743.00 and 743.10-743.12);
cataracts and other lens defects (743.2x and 743.30-743.36);
anotia or microtia (744.01 and 744.23); severe congenital heart disease:
single ventricle, tricuspid atresia, Ebstein anomaly, hypoplastic left heart,
hypoplastic right heart, common truncus, transposition, atrioventricular septal
defects, tetralogy of Fallot, aortic valve atresia or stenosis, coarctation,
total anomalous pulmonary venous return, and anomalous coronary artery
(745.0, 745.1x, 745.2-745.3, 745.6x, 745.7, 746.00, 746.01, 746.1-746.3, 746.7,
746.85,747.1x, 747.22, and 747.41); other congenital heart disease: septal
defects, heterotaxy, partial anomalous pulmonary venous return
(745.4, 745.8, 745.9, 759.3, and 747.42); choanal atresia (748.0); cleft lip
or cleft palate (749.0, 749.00-749.04, 749.1, 749.10-749.14, 749.2, and
749.20-749.25); esophageal atresia with or without tracheoesophageal fistula
(750.3); pyloric stenosis (750.5); intestinal atresia or stenosis (751.1 and 751.2);
biliary atresia (751.61); second- or third-degree hypospadias, (752.61); renal
agenesis or hypoplasia (753.0); renal dysplasia (753.15); congenital
hydronephrosis (753.2x); bladder exstrophy (753.5); posterior urethral valve
or prune belly (753.60 and 756.71); limb deficiency (755.2-755.9); sacral
agenesis (756.13); diaphragmatic hernia (756.6); gastroschisis or omphalocele
(756.72, 756.73, and 756.79).
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ofmortality among smokers carrying the smoking-increasing
allele, which would lead to a negative association between
genotype and likelihood of ever being a smoker at older ages,
when greater differential attrition by genotype has occurred.
Thus another interpretation of the results reported by
Walter and colleagues1 is that the differential association be-
tween BMI-related genetic variants and BMI across birth co-
horts derives from the causal effects of elevated BMI onmor-
tality. Persons inmore recent cohortswereyoungerwhen their
genetic score and BMI were measured, and therefore the as-
sociation is unlikely to be affected by survival bias. Persons in
less recent cohorts were older when measured, thus exclud-
ing those who already died, including through BMI-related
mechanisms.2,3 Some support for this suggestion is found in
Table 1 in the article—for age groups atwhich fewpeople have
died, a positive association between age and BMI (reflecting
the general tendency of BMI to increase with age) was seen,
whereas at older ages there was a negative association.
If BMI is associatedwith increasedmortality, the associa-
tion between BMI and BMI-related variants will be distorted
through collider bias.5 If BMI-related genetic variants are also
associated with increased mortality via mechanisms that do
not involve measured BMI, this will bias the observed asso-
ciations even further. Statistical methods are needed that ac-
count for differential attrition and survival bias.
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To the EditorAstudybyDrWalter and colleagues1 founddiffer-
ential associations between a polygenic genetic risk score and
BMI across different US birth cohorts. In 2015, we published a
study about genetic inheritance and body mass.2 One of our
analyses was basically identical to theirs in which the follow-
inghypothesiswastested:“…that thegenetic influenceonbody
mass is greater amongrecent cohorts thanamongearlierones,”
using data from the Health and Retirement Study (HRS).
Our study used 8816 non-Hispanic white participants,
whereas thestudybyWalterandcolleagues1 also included1306
blackparticipants. Both studies constructed apolygenic score
basedonawell-knowngenome-wide association study.3 Both
studies concluded that increasedgenetic influenceonBMIwas
found in more recent birth cohorts.
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InReplyDrMunafòandcolleaguessuggest thatsurvivalbiasmay
account for our findings of attenuated associations between
genotype and phenotype among cohorts born earlier in the
century.1Althoughweagreethis ismathematicallypossible, the
magnitude of influence of selective survival in our study was
probably minimal. Unlike the age-stratified analyses reported
by Taylor and Munafò,1 our analyses relied on a mixed model
estimated in data with successive enrollments of more recent
birth cohorts. Because of theHRSdesign,wewere able to con-
trol for age, and we estimated genotype-phenotype associa-
tions for members of different birth cohorts at the same age
(65years forwhiteparticipants).Thiseliminatesmostof thepo-
tential forsurvivalbias,butabiascouldstilloccurunder2causal
structures. In one scenario (inwhich genotype influences BMI
andbothBMIandcohort influencesurvival, so that amongsur-
vivors the genotype-BMI association is altered), the magni-
tude of this bias would depend on the differential survival to
the same age of different birth cohorts, and whether that dif-
ferential was due to BMI.
For example, 63% of white individuals born in 1940 sur-
vived to age 65 years, whereas only 52% of white individuals
born in 1920 survived to age 65 years.2 This survival differen-
tial is unlikely to be due to BMI, however, given that nearly
all these improvements in survival were achieved by age 35
years, when BMI-related mortality is unusual.3 In the second
scenario (in which both BMI and genotype have direct effects
on survival, so survival is a collider between them, as Munafó
and colleagues suggest), the magnitude of bias would addi-
tionally depend on the direct effect of the genetic risk score
for BMI (GRS-BMI) on survival. Although this type of survival
bias is plausible, it is small unless the factors have extremely
strong and interactive effects on survival.4,5
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Both scenarios imply that the averageGRS-BMI should be
lower for studyparticipants in earlier birth cohorts.However,
we showed (Table 2 in the article and eTable 1 in the Supple-
ment) that genetic risk remained stable across the birth co-
horts, despite major changes in BMI. Furthermore, GRS-BMI
didnotpredictmortality forwhiteparticipants inHRS(P = .45).
Additionally, we estimated amodel testing whether the birth
year by GRS-BMI interaction differed for white respondents
above or below age 65 years and found no evidence of such
effect modification by age (P = .24).
With respect to Mr Liu and Dr Guo, upon reviewing their
article,6weagreethatourresults forwhiterespondentssubstan-
tiallyoverlapwiththeirs.Thistypeofoverlapisalwaysariskwith
publiclyavailabledatasets suchas theHRS,butmissing their ci-
tationwasamistakeonourpart.Ourmanuscriptwasmostly fin-
ishedprior to theirpublication (first full draft completedMarch
2014).Weattemptedtoupdateourliteraturereview,butwefailed
to identify this important publication.We apologize for our er-
ror.Weconsideritanindicationoftheimportanceofthisresearch
questionthatitwasundertakenbymultipleindependentresearch
groups, andwe are pleased that the findings are consistent.
M.Maria Glymour, ScD
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Iván Mejía-Guevara, PhD
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Assessing the PatientWith Arthralgia, Fevers,
and Rash
TotheEditor In their JAMAClinicalChallengearticle,DrArdalan
and colleagues1 described a patientwith arthralgia and fevers
accompanied by a papulonodular rash, whichwas diagnosed
as erythema nodosum and an adverse reaction to azathio-
prine. The authors supported their diagnosis by noting that
similar caseshavebeen reportedand that theclinical and labo-
ratory findings were consistent with the diagnosis.
We have some skepticism about the diagnosis of ery-
themanodosumandbelieveneutrophilicdermatosis shouldbe
considered.Erythemanodosumisa type IVhypersensitivity re-
action–mediatedconditioncharacterizedbygranulomatous tis-
sue on skin biopsy. Neutrophilic dermatosis is a group of skin
lesions often described in the context of adverse drug reac-
tions, characterizedbyneutrophilic invasionof thedermal tis-
sue, inwhich no granulomatous tissue is observed on biopsy.2
Deposition of small immunocomplexes in the endothelium of
small vessels (type III hypersensitivity reaction) may trigger a
neutrophilic invasion of the vessel wall, leading to stromal ag-
gregationofneutrophilic infiltrates.3Theauthors reported that
conventionalskinbiopsiesareoftennondiagnosticbecauseboth
syndromes present with the same histological image of neu-
trophil invasionof thestromal tissue.However,webelieve that
immunohistochemical assessment of a skin biopsy sample to
detect granulomas should have been performed to differenti-
ate thepossiblediagnosesof thepatient’s skin lesions.Further-
more, the presence of granulomaswould confirm the associa-
tionof thedermal lesionswith autoimmunehepatitis (a type II
andIVhypersensitivityreaction–mediateddisease),whereasab-
senceof granulomatous tissuewould indicate anadverse reac-
tion to azathioprine administration (a type III hypersensitivity
reaction–mediated condition).
Neutrophilic dermatosis is the most common skin ad-
verse reaction associated with azathioprine administration.4
Moreover,elevated levelsofneutrophils in theperipheralblood
are more consistent with neutrophilic dermatosis than with
erythema nodosum. Therefore, we believe that this particu-
lar patient’s clinical presentation, consistingof fevers, arthral-
gia, and skin lesions combined with elevated neutrophil lev-
els in peripheral blood, is more consistent with neutrophilic
dermatosis than with erythema nodosum. Immunohisto-
chemical assessment of a skin biopsy sample would provide
a definite diagnosis of the specific lesions.
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